Latest SEC Filings

VERU INC.Veru Inc. Reports Improved Net Loss of $2.7 Million for Q1 2026, Focuses on Drug Development

Hennessy Capital Investment Corp. VIIHennessy Capital Investment Corp. VII Reports Q1 2026 Financial Results and Merger Update

TABLE TRAC INCTable Trac Reports 10.7% Revenue Increase to $3.91 Million in Q1 2026

OSR Health, Inc.OSR Holdings Reports 36% Decline in Net Sales and Increased Operating Losses in Q1 2026

Greater Cannabis Company, Inc.The Greater Cannabis Company Reports Improved Net Loss of $33,376 in Q1 2026

Canton Strategic Holdings, Inc.Canton Strategic Holdings Reports $47.3 Million Net Loss and Launches Digital Asset Strategy

SEATech Ventures Corp.SEATech Ventures Corp. Reports Q1 2026 Financial Results with Decreased Profit and No Revenue

Onconetix, Inc.Onconetix Reports 78.9% Revenue Decline in Q1 2026, Net Loss Improves to $4.2 Million

Triller Group Inc.Triller Group Reports $32.2M Net Loss, Seeks Funding for Operational Sustainability

INTELLIGENT BIO SOLUTIONS INC.Intelligent Bio Solutions Reports 46% Revenue Growth but Faces Net Loss and Liquidity Concerns

FATE THERAPEUTICS INCFate Therapeutics Reports $31.2 Million Net Loss in Q1 2026

ASTROTECH CorpAstrotech Corporation Reports Revenue Decline and Increased Net Loss for Three and Nine Months Ended March 31, 2026

Lite Strategy, Inc.Lite Strategy, Inc. Reports $23.7 Million Net Loss and Shift to Digital Asset Management

Vor Biopharma Inc.Vor Biopharma Reports $219.6 Million Net Loss in Q1 2026, Focuses on Telitacicept Trials

QT IMAGING HOLDINGS, INC.QT Imaging Reports 133% Revenue Growth to $6.5 Million in Latest Quarter

Protara Therapeutics, Inc.Protara Therapeutics Reports $17.8 Million Net Loss in Q1 2026, Increases R&D Spending

HOOPS SCOUTING USAHoops Scouting USA Reports Significant Net Loss and Decreased Assets for Quarter Ended March 31, 2026

Gyrodyne, LLCGyrodyne Reports Financial Results for Quarter Ending March 31, 2026

VISHAY INTERTECHNOLOGY INCVishay Intertechnology Reports 17.3% Revenue Growth and Net Earnings Turnaround

Century Therapeutics, Inc.Century Therapeutics Reports Significant Financial Decline in Q1 2026

LIQTECH INTERNATIONAL INCLiqTech International Reports $4.14 Million Revenue in Q1 2026, Net Loss Increases to $2.73 Million

Tyra Biosciences, Inc.Tyra Biosciences Reports $39.3 Million Net Loss and $412 Million in Total Assets for Q1 2026

ABEONA THERAPEUTICS INC.Abeona Therapeutics Reports $8.7M Product Revenue and $17.1M Net Loss in Q1 2026

Paysign, Inc.Paysign Reports 50.8% Revenue Growth to $28.0 Million in Latest Quarter

Marathon Bancorp, Inc. /MD/Marathon Bancorp Reports 228.7% Increase in Quarterly Net Income